Endometrial polyp stem cell
View Patent ↗An endometrial polyp stem cell is disclosed in the present invention. The endometrial polyp stem cell is isolated from an endometrial polyp tissue, expresses vimentin, CD13, CD29, CD44, and CD90, and has no expression of CD1q, CD3, CD34, and CD45.
1. A formulation comprising: an endometrial polyp stem cell, which is isolated from an endometrial polyp tissue wherein the endometrial polyp stem cell expresses vimentin, CD13, CD29, CD44, and CD90, and has TERT expression statistically significantly lower than a human embryonic stem cell or a cancer cell, and an osteogenic medium comprising dexamethasone, β-glycerol phosphate, and ascorbate.
2. The formulation of claim 1 , wherein the endometrial polyp stem cell has no expression of CD3, CD34, and CD45.
3. The formulation of claim 1 , wherein the endometrial polyp tissue is obtained from endometrium of a hysterectomy specimen.
4. The formulation of claim 1 , wherein the endometrial polyp stem cell has clonogenicity.